Comparison of FDA Approved Kinase Targets to Clinical Trial Ones: Insights from Their System Profiles and Drug-Target Interaction Networks

Kinase is one of the most productive classes of established targets, but the majority of approved drugs against kinase were developed only for cancer. Intensive efforts were therefore exerted for releasing its therapeutic potential by discovering new therapeutic area. Kinases in clinical trial could...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Jingyu, Wang, Panpan, Yang, Hong, Zhou, Jin, Li, Yinghong, Li, Xiaoxu, Xue, Weiwei, Yu, Chunyan, Tian, Yubin, Zhu, Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4980536/
https://www.ncbi.nlm.nih.gov/pubmed/27547755
http://dx.doi.org/10.1155/2016/2509385

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4980536/
https://www.ncbi.nlm.nih.gov/pubmed/27547755
http://dx.doi.org/10.1155/2016/2509385

Ejemplares similares